Vijaya Diagnostic Centre Limited
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Vijaya Diagnostic Centre Limited's yearly results (2023–2026), compared with Healthcare companies in India. Tap ? on any ratio for what it means.
What stands out
- Cash Locked Ratio: Money owed to suppliers is larger than money owed by customers plus stock: ₹3 per ₹100 of sales comes from others' credit, against ₹5 from others' credit three years earlier. Less money tied up than 90% of Healthcare companies in India.
Where ₹100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
₹156Over the last 3 years, every ₹100 of reported profit came with ₹156 of operating cash.
Higher than 74% of Healthcare companies in India.
Self-Funding Ratio
1.9×Over the last 3 years its own operating cash covered its investment spending (capex) 1.9 times.
Higher than 65% of Healthcare companies in India.
Cash Locked Ratio
−₹3Money owed to suppliers is larger than money owed by customers plus stock: ₹3 per ₹100 of sales comes from others' credit, against ₹5 from others' credit three years earlier.
Less money tied up than 90% of Healthcare companies in India.
Growth quality
Steadiness Ratio
3/3 · 3/3Sales and profit both grew in each of the last 3 years.
Steadier than 83% of Healthcare companies in India.
Growth Efficiency Ratio
₹25Sales grew 77% in 3 years; of every extra ₹100 of sales, ₹25 became extra profit.
Higher than 71% of Healthcare companies in India.
Asset Productivity Ratio
+77% / +77%In 3 years sales changed by +77% while total assets changed by +77%. Both moved at about the same pace.
Balance-sheet strength
Debt Due Cover Ratio
12.0×Debt due within a year is covered 12.0 times by its yearly operating cash.
Higher than 79% of Healthcare companies in India.
Cash Cushion Ratio
−1%Debt, after subtracting cash, equals 1% of its market value (net debt).
Higher than 52% of Healthcare companies in India.
Tangible Assets Ratio
91%Of every ₹100 the company owns, ₹91 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 68% of Healthcare companies in India.
Tangible Net Worth Ratio
85%Of every ₹100 of net worth, ₹85 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 68% of Healthcare companies in India.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Vijaya Diagnostic Centre Limited owes ₹0.36 for every ₹1 it owns. Net profit rose 20% in the year to Mar 2026, and grew 27% a year on average over 3 years.
Compared with Healthcare companies in India · latest annual results Mar 2026.
P/E ratio
76.5Investors pay ₹76.5 for every ₹1 of Vijaya Diagnostic Centre Limited's yearly profit, higher than 84% of Healthcare companies in India.
P/B ratio
14.97The share price is 14.97 times Vijaya Diagnostic Centre Limited's book value per share, higher than 94% of Healthcare companies in India.
Market cap
₹14,325 CrThe total market value of all of Vijaya Diagnostic Centre Limited's shares at today's price (share price × number of shares), larger than 68% of Healthcare companies in India. PosiCap size class: Meso Cap.
Net worth (book value)
₹957 CrWhat Vijaya Diagnostic Centre Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
₹92.93Net worth divided by the number of shares. The share price of ₹1,391 is 15.0 times this, which is the P/B above.
Return on equity (ROE)
19.6%Vijaya Diagnostic Centre Limited earned 19.6% on its shareholders' money over the last year, higher than 79% of Healthcare companies in India.
Owes vs Owns
0.36×Vijaya Diagnostic Centre Limited owes ₹0.36 for every ₹1 it owns (low), lower than 52% of Healthcare companies in India.
Dividend yield
0.14%Vijaya Diagnostic Centre Limited pays 0.14% of its share price as dividends a year, lower than 80% of dividend-paying Healthcare companies in India.
Revenue growth
+20%Revenue rose 20% in the year to Mar 2026, and grew 21% a year on average over 3 years.
Profit growth
+20%Net profit rose 20% in the year to Mar 2026, and grew 27% a year on average over 3 years.
Profit margin
21.3%Vijaya Diagnostic Centre Limited keeps ₹21 of every ₹100 of revenue as net profit.
Cash quality
1.6×Cash from Vijaya Diagnostic Centre Limited's business was 1.6× its reported profit in the year to Mar 2026 — its profit turned into cash.
Interest cover
7.8×Vijaya Diagnostic Centre Limited's operating profit covered its interest costs 7.8 times in the year to Mar 2026.
Cash vs debt
Net debtVijaya Diagnostic Centre Limited had ₹135 Cr more debt than cash (net debt) at Mar 2026.
Questions
What is Vijaya Diagnostic Centre Limited's P/E ratio?
Investors pay ₹76.5 for every ₹1 of Vijaya Diagnostic Centre Limited's yearly profit, higher than 84% of Healthcare companies in India.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Vijaya Diagnostic Centre Limited: ₹14,325 Cr ÷ ₹957 Cr (31 Mar 2026) = 15.0.
What is Vijaya Diagnostic Centre Limited's return on equity?
Vijaya Diagnostic Centre Limited earned 19.6% on its shareholders' money over the last year, higher than 79% of Healthcare companies in India.
How much does Vijaya Diagnostic Centre Limited owe compared with what it owns?
Vijaya Diagnostic Centre Limited owes ₹0.36 for every ₹1 it owns (low), lower than 52% of Healthcare companies in India.
Does Vijaya Diagnostic Centre Limited pay a dividend?
Yes. Vijaya Diagnostic Centre Limited pays 0.14% of its share price as dividends a year, lower than 80% of dividend-paying Healthcare companies in India.
Is Vijaya Diagnostic Centre Limited's revenue growing?
Revenue rose 20% in the year to Mar 2026, and grew 21% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.